180 Life Sciences
Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate,combination therapy.

$4.6M

Market Cap • 1/30/2025

2016

(9 years)
Founded

2017

(8 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Palo Alto

Headquarters • California